Compare Indokem with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.51%
- Poor long term growth as Net Sales has grown by an annual rate of 13.02% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.94 times
Flat results in Dec 25
With ROCE of 8.8, it has a Very Expensive valuation with a 18.5 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.31% of the company
Stock DNA
Specialty Chemicals
INR 1,548 Cr (Micro Cap)
286.00
21
0.00%
0.32
8.95%
23.81
Total Returns (Price + Dividend) 
Indokem for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Indokem Ltd is Rated Sell by MarketsMOJO
Indokem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Indokem Ltd is Rated Sell
Indokem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Dec 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 07 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Indokem Ltd is Rated Sell
Indokem Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article Announcements 
Closure of Trading Window
23-Mar-2026 | Source : BSEIntimation of Closure of Trading window from Wednesday 1st April 2026 till 48 hours after the declaration of Financial Results of the Company for the Quarter and Financial year ended 31st March 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
17-Mar-2026 | Source : BSENewspaper Publication for information regarding Special Window for re-lodgement for transfer request of physical securities.
Announcement Under Regulation 30 (LODR)
17-Feb-2026 | Source : BSEPursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 and with reference to our earlier intimation dated 08th August 2025 we hereby inform you that the Strategic Marketing Partnership Agreement dated 08th August 2025 entered into with RDX Digital Technologies a sole proprietorship based in Coimbatore Tamilnadu has been terminated with effect from 17th February 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 10 Schemes (0.1%)
Held by 0 FIIs
Vindhyapriya Holdings Pvt Ltd (19.76%)
Sangeetha S (1.79%)
25.95%
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is -3.18% vs 7.80% in Dec 2024
YoY Growth in quarter ended Dec 2025 is -44.59% vs 628.57% in Dec 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 1.99% vs -5.01% in Sep 2024
Growth in half year ended Sep 2025 is 180.43% vs 72.67% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.18% vs -0.87% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 337.50% vs 87.67% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 8.06% vs 47.33% in Mar 2024
YoY Growth in year ended Mar 2025 is 151.21% vs -2,096.77% in Mar 2024






